A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for ChildrenWith Newly Diagnosed High-Risk Neuroblastoma (NBL)

Project: Research project

Project Details

Description

A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
StatusActive
Effective start/end date1/1/22 → 12/31/25

Funding

  • PUBLIC HEALTH INSTITUTE
  • JUBILANT DRAXLMAGE INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint